Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Medtronic plc
Bear Case (25th pct.)
-37.1% vs price
Base Case (Median)
-31.6% vs price
Bull Case (75th pct.)
-9.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $130.80 | 43.8% | High (40%) |
| PE Comparable | $89.71 | -1.4% | Medium (25%) |
| Growth Trajectory DCF | $62.26 | -31.6% | Medium (20%) |
| Graham Number | $59.42 | -34.7% | Medium (40%) |
| EV/EBITDA | $55.06 | -39.5% | Medium (20%) |
| EV/FCF | $74.51 | -18.1% | Medium (20%) |
| Earnings Power Value | $48.63 | -46.5% | Medium (50%) |
Based on 7 out of 7 methods, MDT appears overvalued at the current price of $90.96. The base case fair value of $62.26 implies 31.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.